With respect to the Soucek et al abstract to be presented on 20 April at the American Council of Cancer Research’s Annual Meeting , from the abstract body
Here we discuss our current research with Omomyc and our efforts to develop a clinically viable approach to Myc inhibition.
One is based on the direct use of Omomyc itself as a peptide since we have discovered that it natively possesses cell-penetrating activity and it rapidly biodistributes to the lung and brain after intranasal administration.
What does “natively possesses” mean in this context?
- Forums
- ASX - By Stock
- pathway to a collaboration
PYC
pyc therapeutics limited
Add to My Watchlist
1.18%
!
$1.29

With respect to the Soucek et al abstract to be presented on 20...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.29 |
Change
0.015(1.18%) |
Mkt cap ! $749.4M |
Open | High | Low | Value | Volume |
$1.27 | $1.29 | $1.27 | $13.77K | 10.73K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 7873 | $1.27 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.29 | 715 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 7873 | 1.270 |
1 | 13987 | 1.265 |
2 | 15405 | 1.260 |
1 | 12000 | 1.255 |
2 | 2005 | 1.250 |
Price($) | Vol. | No. |
---|---|---|
1.285 | 701 | 1 |
1.290 | 25630 | 2 |
1.295 | 24500 | 1 |
1.300 | 86573 | 6 |
1.305 | 10000 | 1 |
Last trade - 10.36am 30/06/2025 (20 minute delay) ? |
Featured News
PYC (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online